Kynexis Therapeutics
PrivateLast Round
Series A
Aug 19, 2026
Total Funding Raised
$220M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Kynexis Therapeutics is a biotechnology company developing precision therapeutics for brain diseases, with a focus on cognitive impairment associated with schizophrenia (CIAS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kynexis Therapeutics Comparables
Compare Kynexis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Monument Therapeutics | 81% | |
| Neurosterix | 79% | |
| Alto Neuroscience | 77% | |
Kynexis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 19, 2026 | ||||
| Series A | Nov 7, 2023 |
Kynexis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion | Series A |
| Ysios Capital | Series A |
| Sunstone Life Science Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 19, 2026
$110M round led by nvfund
- May 20, 2026
Grew 16% QoQ, from 19 to 22 employees.
Kynexis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kynexis Therapeutics's valuation, stock price, and market status.